SK바이오사이언스

302440KOSPI

49.7 / 100

Reference Date: 2026-09-08

Financial Score17.5 / 40

News Sentiment18.2 / 25

Momentum7.0 / 20

Disclosure7.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Slightly up 2.0% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

SK Bioscience, established in 2018 as a spin-off from SK Chemicals, focuses on vaccine development and global CDMO services. Key products include cell-culture influenza vaccines like 'SkyCellflu' and the COVID-19 vaccine 'SkyCovion,' which received WHO PQ certification and global approvals. The company also provides CDMO services, collaborating with global pharmaceutical firms to produce and develop vaccines.

Number of Employees

1,129people

Average Salary

67.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

1.45Industry Average 1.202.5Point

Higher than industry avg (caution)

ROE

-2.77Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

29.06Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲57.9% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼522.0% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -1.4% (declining, 3yr)

Detailed News Sentiment

22 totalPositive 16Neutral 5Negative 1Average Sentiment Score 73

Positive
박찬대 ‘1호 공약’ 인천바이오과학기술원 ‘시동’…당위성 및 입지...
SK바이오사이언스 관련 직접적 영향은 제한적이나, 인천바이오과학기술원 설립 추진은 바이오 산업 분야의 긍정적 발전을 시사하며 관련 기업에 대한 간접적인 긍정적 영향 기대.
Positive
모더나, 맞춤형 암백신 넘어 ‘범용 암백신’ 만든다
SK바이오사이언스와 관련 연구 기관들의 mRNA 기술 활용 확대가 긍정적 영향을 미칠 것으로 예상됨.
Positive
본업 탄탄한데 신사업도 기대…"SK케미칼, 성장동력 더해졌다"
SK케미칼의 신사업 확장이 기대되어 긍정적인 전망을 제공함.

Detailed Momentum

52-week position1.0Point

Near 52w low (18%, downtrend)

Current 37,600Won52-week high 60,10052-week low 32,500

1-month return4.0Point

1m +2.04% (slight rise)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

5 totalPositive 0Neutral 4Negative 1

Neutral대규모기업집단현황공시[분기별공시(개별회사용)]2026-08-28
Negative지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항2026-08-14
Neutral반기보고서 (2026.06)2026-08-13
Neutral연결재무제표기준영업(잠정)실적(공정공시)2026-08-10
Neutral기업설명회(IR)개최(안내공시)2026-08-10